Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Adam Hall, 42, of Donvale Road,, Tyne and Wear, is charged with 16 offences, all of which he denies. | ITV News Tyne Tees ...

A man has appeared in court to deny multiple counts of rape and intentionally transmitting HIV. Adam Hall, 42, of Donvale ...

The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is starting to fail. When ...

Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

A recent study shows a substantial decline in the use of nonrecommended antiviral prescriptions among Medicare beneficiaries ...

The US Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients. The ...